Kyverna Therapeutics, Inc.
Assets & Liabilities
| Period | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| Mar 2023 | — | — | $39.8M |
| Jun 2023 | — | — | $53.4M |
| Sep 2023 | — | — | $23.0M |
| Dec 2023 | $26.0M | $75.2M | $34.6M |
| Mar 2024 | $29.0M | $390.0M | $224.3M |
| Jun 2024 | $29.6M | $363.1M | $131.6M |
| Sep 2024 | $36.5M | $339.2M | $104.7M |
| Dec 2024 | $38.1M | $304.6M | $96.6M |
| Mar 2025 | $36.6M | $260.7M | $56.9M |
| Jun 2025 | $42.1M | $226.5M | $53.4M |
| Sep 2025 | $35.2M | $187.2M | $34.2M |
| Dec 2025 | $61.6M | $293.8M | $124.1M |
| Mar 2026 | $61.4M | $257.0M | $32.2M |
| Jun 2026 | $54.3M | $219.8M | $31.8M |